Tanito, K.; Nii, T.; Wakuya, K.; Hamabe, Y.; Yoshimi, T.; Hosokawa, T.; Kishimura, A.; Mori, T.; Katayama, Y.
Inflammation-Triggering Engineered Macrophages (MacTriggers) Enhance Reactivity of Immune Checkpoint Inhibitor Only in Tumor Tissues. Cancers 2024, 16, 3787.
https://doi.org/10.3390/cancers16223787
AMA Style
Tanito K, Nii T, Wakuya K, Hamabe Y, Yoshimi T, Hosokawa T, Kishimura A, Mori T, Katayama Y.
Inflammation-Triggering Engineered Macrophages (MacTriggers) Enhance Reactivity of Immune Checkpoint Inhibitor Only in Tumor Tissues. Cancers. 2024; 16(22):3787.
https://doi.org/10.3390/cancers16223787
Chicago/Turabian Style
Tanito, Kenta, Teruki Nii, Kanae Wakuya, Yusuke Hamabe, Toma Yoshimi, Takanatsu Hosokawa, Akihiro Kishimura, Takeshi Mori, and Yoshiki Katayama.
2024. "Inflammation-Triggering Engineered Macrophages (MacTriggers) Enhance Reactivity of Immune Checkpoint Inhibitor Only in Tumor Tissues" Cancers 16, no. 22: 3787.
https://doi.org/10.3390/cancers16223787
APA Style
Tanito, K., Nii, T., Wakuya, K., Hamabe, Y., Yoshimi, T., Hosokawa, T., Kishimura, A., Mori, T., & Katayama, Y.
(2024). Inflammation-Triggering Engineered Macrophages (MacTriggers) Enhance Reactivity of Immune Checkpoint Inhibitor Only in Tumor Tissues. Cancers, 16(22), 3787.
https://doi.org/10.3390/cancers16223787
